文献速递胃肠外科围术期管理与 ERAS

减重手术术前抗凝与更差结局相关

Preoperative anticoagulation in patients undergoing bariatric surgery is associated with worse outcomes.
PubMed 文献 · Surg Endosc · 2019-10-15

基于MBSAQIP 2015–2016数据,纳入269,243例接受AGB、SG或RYGB的患者,其中6,541例(2.43%)术前使用抗凝。多因素回归显示术前抗凝与出血、DVT、30天再入院/再手术/再干预、死亡风险升高及住院时间延长相关。

要点

  • 术前抗凝者出血风险OR 2.7,DVT风险OR 2.8。
  • 术前抗凝者30天再入院OR 2.1,死亡OR 2.9。
  • 需重视术后抗凝方案以改善该组结局。

核心结论

  • 减重手术术前抗凝患者术后结局更差,围术期发病率和死亡率升高。

研究设计与样本

  • 回顾性队列研究,使用MBSAQIP 2015–2016数据集,纳入269,243例接受AGB、SG或RYGB的患者,其中6,541例(2.43%)术前抗凝。

主要发现

  • 输血、DVT、PE发生率分别为0.67%、0.18%、0.11%。
  • 术前抗凝者出血风险OR 2.7(95%CI 2.3-3.3,p<0.0001),DVT风险OR 2.8(95%CI 1.9-4,p<0.0001)。
  • 术前抗凝者30天再入院OR 2.1(95%CI 1.9-2.3,p<0.0001)、再手术OR 1.5(95%CI 1.2-1.7,p<0.0001)、再干预OR 2.1(95%CI 1.8-2.4,p<0.0001)。
  • 术前抗凝者死亡OR 2.9(95%CI 2.04-4.069,p<0.0001),住院时间延长(ratio 1.2,95%CI 1.199-1.241,p<0.0001)。

临床怎么用

  • 减重外科医生应认识到术前抗凝患者术后发病率和死亡率升高。
  • 通过密切关注术后抗凝方案来改善该组患者结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Management of patients on chronic anticoagulation (AC) in bariatric surgery may present a challenge, as there is a delicate balance between risks of bleeding and thrombotic events, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). The purpose of this study was to evaluate and compare rates of bleeding, thrombotic events, and outcomes of patients on preoperative AC during bariatric surgery. METHODS: The MBSAQIP data sets for 2015 and 2016 was used to identify all patients undergoing adjustable gastric banding (AGB), sleeve gastrectomy (SG), and Roux-en-Y gastric bypass (RYGB). Clinical outcomes included length of stay, 30-day readmission, 30-day reoperations and interventions, perioperative and 30-day death events, need for transfusion, PE, and DVT. Following univariate analysis, multivariable logistic regression models and generalized linear regression model for a negative binomial distributed count outcomes were used after adjusting for surgery type and other factors related to each outcome. RESULTS: There were 269,243 records extracted, as there were 6541 (2.43%) patients on preoperative AC. Rates of transfusion, DVT, and PE were 0.67%, 0.18%, and 0.11%. Following multivariable logistic regression, patients with preoperative AC had higher risks of bleeding and DVT (OR 2.7, 95% CI 2.3-3.3, p-value < 0.0001 and OR 2.8, 95% CI 1.9-4, p-value < 0.0001, respectively). In addition, patients with pre-op AC had a higher risk of 30-day readmission (OR 2.1, 95% CI 1.9-2.3, p < 0.0001)/reoperation (OR 1.5, 95% CI 1.2-1.7, p < 0.0001)/reintervention (OR 2.1, 95% CI 1.8-2.4, p < 0.0001), mortality (OR 2.9, 95% CI 2.04-4.069, p < 0.0001), and longer LOS (ratio 1.2, 95% CI 1.199-1.241, p < 0.0001). CONCLUSION: Patients with preoperative AC had worse postoperative outcomes. Bariatric surgeons should be aware of the increased morbidity and mortality, and care must be taken to improve outcomes through close attention to postoperative AC protocols in this group of patients.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Altieri MS, Yang J, Zhu C, et al. Preoperative anticoagulation in patients undergoing bariatric surgery is associated with worse outcomes. Surg Endosc. 2019. PMID: 31617101. doi:10.1007/s00464-019-07191-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。